Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani

Mycoses. 2006 Mar;49(2):109-13. doi: 10.1111/j.1439-0507.2006.01202.x.

Abstract

Fusarium spp. have emerged as important causes of invasive fungal infections in immunocompromised patients. Rabbit pulmonary alveolar macrophages (PAMs) exhibited fungicidal activity against conidia of Fusarium solani and achieved a time-dependent increase in killing. Neither deoxycholate amphotericin B (DAMB) nor amphotericin B lipid complex (ABLC) exerted a suppressive effect on PAMs by decreasing their conidiocidal activity against F. solani. On the contrary, at a concentration of 0.125 microg ml(-1), ABLC and, to a lesser degree, DAMB additively augmented the fungicidal activity of pulmonary alveolar macrophages against conidia of Fusarium solani.

MeSH terms

  • Amphotericin B / pharmacology*
  • Animals
  • Antifungal Agents / pharmacology*
  • Cells, Cultured
  • Deoxycholic Acid / pharmacology*
  • Drug Combinations
  • Female
  • Fusarium / drug effects*
  • Fusarium / immunology*
  • Humans
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / immunology*
  • Phosphatidylcholines / pharmacology*
  • Phosphatidylglycerols / pharmacology*
  • Rabbits

Substances

  • Antifungal Agents
  • Drug Combinations
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • liposomal amphotericin B
  • Deoxycholic Acid
  • Amphotericin B
  • amphotericin B, deoxycholate drug combination